showed that a consortium of 11 bacterial strains obtained from healthy human donors can boost the efficacy of anti-PD-1 immunotherapy in suppressing adenocarcinoma and melanoma growth in mice by increasing the infiltration of IFN-γ+ CD8+ T cells in the tumor microenvironment (148). The gene discussed is CD8A; the disease is melanoma.